The Australian Traumatic Brain Injury Initiative: systematic review of the effect of acute interventions on outcome for people with moderate-severe traumatic brain injury.

ADULT BRAIN INJURY CLINICAL MANAGEMENT OF CNS INJURY PEDIATRIC BRAIN INJURY TRAUMATIC BRAIN INJURY

Journal

Journal of neurotrauma
ISSN: 1557-9042
Titre abrégé: J Neurotrauma
Pays: United States
ID NLM: 8811626

Informations de publication

Date de publication:
27 Jan 2024
Historique:
medline: 28 1 2024
pubmed: 28 1 2024
entrez: 27 1 2024
Statut: aheadofprint

Résumé

The Australian Traumatic Brain Injury Initiative (AUS-TBI) is developing a data resource to enable improved outcome prediction for people with moderate-severe TBI (msTBI) across Australia. Fundamental to this resource is the collaboratively designed data dictionary. This systematic review and consultation aimed to identify acute interventions with potential to modify clinical outcomes for people after msTBI, inclusion in a data dictionary. Standardised searches were implemented across bibliographic databases from inception through April 2022. English-language reports of randomised controlled trials (RCTs) evaluating any association between any acute intervention and clinical outcome, in at least 100 patients with msTBI were included. A predefined algorithm was used to assign a value to each observed association. Consultation with AUS-TBI clinicians and researchers formed the consensus process for interventions to be included in a single data dictionary. Searches retrieved 14,455 records, of which 124 full-length RCTs were screened, with 35 studies included. These studies evaluated 26 unique acute interventions across 21 unique clinical outcomes. Only four interventions were considered to have medium modifying value for any outcome from the review, with an additional eight interventions agreed upon through the consensus process. The interventions with medium value were tranexamic acid and phenytoin, which had a positive effect on an outcome; and decompressive craniectomy surgery and hypothermia, which negatively affected outcomes. From the systematic review and consensus process, 12 interventions were identified as potential modifiers to be included in the AUS-TBI national data resource.

Sections du résumé

BACKGROUND BACKGROUND
The Australian Traumatic Brain Injury Initiative (AUS-TBI) is developing a data resource to enable improved outcome prediction for people with moderate-severe TBI (msTBI) across Australia. Fundamental to this resource is the collaboratively designed data dictionary. This systematic review and consultation aimed to identify acute interventions with potential to modify clinical outcomes for people after msTBI, inclusion in a data dictionary.
METHODS METHODS
Standardised searches were implemented across bibliographic databases from inception through April 2022. English-language reports of randomised controlled trials (RCTs) evaluating any association between any acute intervention and clinical outcome, in at least 100 patients with msTBI were included. A predefined algorithm was used to assign a value to each observed association. Consultation with AUS-TBI clinicians and researchers formed the consensus process for interventions to be included in a single data dictionary.
FINDINGS RESULTS
Searches retrieved 14,455 records, of which 124 full-length RCTs were screened, with 35 studies included. These studies evaluated 26 unique acute interventions across 21 unique clinical outcomes. Only four interventions were considered to have medium modifying value for any outcome from the review, with an additional eight interventions agreed upon through the consensus process. The interventions with medium value were tranexamic acid and phenytoin, which had a positive effect on an outcome; and decompressive craniectomy surgery and hypothermia, which negatively affected outcomes.
CONCLUSIONS CONCLUSIONS
From the systematic review and consensus process, 12 interventions were identified as potential modifiers to be included in the AUS-TBI national data resource.

Identifiants

pubmed: 38279797
doi: 10.1089/neu.2023.0465
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Jemma Keeves (J)

Perth, Australia; jemma.keeves@curtin.edu.au.

Adelle Gadowski (A)

Melbourne, Australia; adelle.gadowski@monash.edu.

Ancelin McKimmie (A)

Melbourne, Australia; ancelin.mckimmie@monash.edu.

Matthew Bagg (M)

Perth, Australia; matthew.bagg@nd.edu.au.

Ana Antonic-Baker (A)

Melbourne, Australia; ana.antonic-baker@monash.edu.

Nyssa Clarke (N)

Melbourne, Australia; nyssa.clarke@monash.edu.

Sandra Reeder (S)

Melbourne, Australia; sandra.reeder@monash.edu.

Amelia Hicks (A)

Monash University, 2541, Monash-Epworth Rehabilitation Research Centre, 185-187 Hoddle St, Clayton, Victoria, Australia, 3800.
Monash University, 2541, Monash University, 13 Ranfurlie Crescent, 13 Ranfurlie Crescent, Clayton, Victoria, Australia, 3800; amelia.hicks@mountsinai.org.

Alastair Brown (A)

Melbourne, Australia; alastair.brown@monash.edu.

Robert McNamara (R)

Royal Perth Hospital, 6508, Department of Intensive Care Medicine, Wellington Street Campus, Level 4, North Block, Perth, Western Australia, Australia, 6000; Robert.Mcnamara@health.wa.gov.au.

Cristina Roman (C)

Melbourne, Australia; C.roman@alfred.org.au.

Toby Jeffcote (T)

Melbourne, Australia; Toby.Jeffcote@monash.edu.

Lorena Romero (L)

Melbourne, Australia; L.Romero@alfred.org.au.

Regina Hill (R)

Melbourne, Australia; reginahill@effectiveconsulting.com.au.

Jennie Ponsford (J)

Monash University, School of Psychological Sciences , 18 Innovation Walk, Clayton, Victoria, Australia, 3800.
Monash Epworth Rehabilitation Research Centre, Epworth Healthcare, 185-187 Hoddle Street, Richmond, Victoria, Australia; jennie.ponsford@monash.edu.

Natasha A Lannin (NA)

Monash University, 2541, Department of Neuroscience, Central Clinical School, 99 Commercial Rd, Melbourne, Victoria, Australia, 3004.
Alfred Health, 5392, 55 Commercial Rd, Melbourne, Victoria, Australia, 3181; natasha.lannin@monash.edu.

Terence J O'Brien (TJ)

Monash University, Neuroscience, Melbourne, Victoria, Australia.
Melbourne Health, 6451, Department of Neurology, Parkville, Victoria, Australia.
Alfred Health, 5392, Department of Neurology, Melbourne, Victoria, Australia.
The University of Melbourne, 2281, Department of Medicine, Melbourne, Victoria, Australia; terence.obrien@monash.edu.

Peter Cameron (P)

Monash Unniversity, Epidemiology and Preventive Medicine, Commercial Rd Prarhan, Melbourne, Victoria, Australia, 3000; peter.cameron@monash.edu.

Nick Rushworth (N)

Brain Injury Australia, Sydney, New South Wales, Australia; nick.rushworth@braininjuryaustralia.org.au.

Melinda Fitzgerald (M)

Curtin University, Curtin Health Innovation Research Institute, Building RR, QEII Medical Centre, 8 Verdun St, Nedlands, Western Australia, Australia, 6009; lindy.fitzgerald@curtin.edu.au.

Belinda Gabbe (B)

Melbourne, Australia; belinda.gabbe@monash.edu.

D James Cooper (DJ)

The Alfred, Intensive Care, Commercial Road, Melbourne, Victoria, Australia, 3004.
Monash University, ANZIC-RC, Level 6, The Alfred Centre, 99 Commercial Road, Melbourne, Victoria, Australia, 3004; jamie.cooper@monash.edu.

Classifications MeSH